News from bacterin international holdings, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 07, 2012, 16:00 ET

Bacterin Reports Third Quarter 2012 Financial Results

 Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Oct 23, 2012, 12:05 ET

Bacterin to Present at 7th Annual Singular Research Conference

 Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Sep 12, 2012, 09:53 ET

John Deedrick Joins Bacterin Board of Directors

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings...

Sep 11, 2012, 09:00 ET

Positive Clinical Results on the use of Bacterin's OsteoSponge® SC Product for Regeneration of Subchondral Bone Published in Foot & Ankle Specialist

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings...

Aug 31, 2012, 09:00 ET

Bacterin International to Present at Stifel Nicolaus 2012 Healthcare Conference on September 6, 2012

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Aug 28, 2012, 08:30 ET

Bacterin Secures $25 Million Financing with OrbiMed

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of unique bone graft material and antimicrobial coatings for...

Aug 09, 2012, 16:00 ET

Bacterin International Announces Second Quarter and Six Months 2012 Financial Results

 Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Jul 27, 2012, 09:00 ET

Bacterin International Holdings, Inc. Schedules Second Quarter 2012 Financial Earnings Conference Call

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and...

Jul 10, 2012, 08:44 ET

Bacterin International Signs Its Fourth National GPO Contract with the Premier healthcare alliance

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Jul 03, 2012, 16:00 ET

Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders

Bacterin International Holdings, Inc. (NYSE MKT LLC: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

May 30, 2012, 16:00 ET

Bacterin to Present at the Jefferies 2012 Global Healthcare Conference

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

May 08, 2012, 08:30 ET

Bacterin International Signs Its Third National GPO Contract with Novation

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

May 03, 2012, 16:00 ET

Bacterin Announces First Quarter 2012 Revenue of $7.8 Million, Up 29% Year-over-Year, on Gross Margins of 76%, and 34% Reduction in Operating Loss

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Apr 24, 2012, 16:22 ET

Bacterin International Holdings, Inc. Schedules First Quarter 2012 Financial Earnings Conference Call

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Apr 24, 2012, 07:00 ET

Bacterin Secures Accounts Receivable Credit Facility

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Apr 04, 2012, 07:00 ET

Peer Review Determines Bacterin's OsteoSponge® Superior to Autograft and Ideal for Bone Regeneration in Dove Press Journal

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Mar 12, 2012, 16:00 ET

Bacterin to Present at the 5th Annual Maxim Group Growth Conference on March 26, 2012

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Feb 10, 2012, 17:54 ET

Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge® Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and...

Feb 07, 2012, 09:00 ET

Bacterin Promotes Seasoned Healthcare Sales Professional to National Sales Manager

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Feb 01, 2012, 16:10 ET

Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...